Pandora A/S
Major shareholder announcement
Major shareholder announcement
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that
BlackRock, Inc. has notified the company that it now holds 7,519,559 shares, corresponding to 9.51% of the total voting rights and share capital (previously 9.5%). Additionally, BlackRock, Inc. controls voting rights attached to financial instruments amounting to 0.49% (previously 0.49%). In total, BlackRock, Inc. control 10.01% of the company’s voting rights (previously 9.99%).
ABOUT PANDORA
Pandora is the world's largest jewellery brand, specialising in the design, crafting and marketing of accessible luxury jewellery made from high-quality materials. Each piece is created to inspire self-expression, allowing people to share their stories and passions through meaningful jewellery. Pandora jewellery is sold in more than 100 countries through 6,800 points of sale, including more than 2,700 concept stores.
Headquartered in Copenhagen, Denmark, Pandora employs 37,000 people worldwide and crafts its jewellery using only recycled silver and gold. Pandora is committed to leadership in sustainability and has set out to halve greenhouse gas emissions across its value chain by 2030. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated revenue of DKK 31.7 billion (EUR 4.2 billion) in 2024.
CONTACT
For more information, please contact:
Investor Relations BILAL AZIZ SVP, Investor Relations & Treasury +45 3137 9486 biazi@pandora.net | Corporate Communications JOHAN MELCHIOR VP, Media Relations & Public Affairs +45 4060 1415 jome@pandora.net |
ADAM FUGLSANG Director, Investor Relations +45 6167 7425 adfug@pandora.net | |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brookfield Corporation23.6.2025 22:45:00 CEST | Press release
Brookfield Corporation Announces Results of Conversion of its Series 42 Preferred Shares
Novo Nordisk A/S23.6.2025 20:36:11 CEST | Press release
Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities
PhysicsX23.6.2025 18:38:20 CEST | Press release
PhysicsX Raises $135M Series B to Usher in a New Era of AI-Native Engineering and Manufacturing
Wolters Kluwer N.V.23.6.2025 17:30:00 CEST | Press release
Wolters Kluwer successfully prices €500 million five-year Eurobond
ACI23.6.2025 16:34:07 CEST | Press release
ACI, Council of State refers decision on commissioner appointment back to TAR for full review
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom